Lixte Biotech Hlds
(LIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 1,009 | 967 | 1,026 | 1,024 | 1,670 |
| Operating Income | -1,009 | -967 | -1,026 | -1,024 | -1,670 |
| Interest Expense | 4 | 7 | 10 | 0 | 2 |
| Other Income | 3 | 3 | 4 | 6 | 4 |
| Pre-tax Income | -1,011 | -971 | -1,032 | -1,019 | -1,668 |
| Net Income Continuous | -1,011 | -971 | -1,032 | -1,019 | -1,668 |
| Net Income | $-1,011 | $-971 | $-1,032 | $-1,019 | $-1,668 |
| EPS Basic Total Ops | -0.45 | -0.43 | -0.35 | -0.49 | -1.00 |
| EPS Basic Continuous Ops | -0.45 | -0.43 | -0.34 | -0.49 | -1.00 |
| EPS Diluted Total Ops | -0.45 | -0.43 | -0.35 | -0.49 | -1.00 |
| EPS Diluted Continuous Ops | -0.45 | -0.43 | -0.34 | -0.49 | -1.00 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.43 | -0.41 | N/A | N/A |
| EBITDA(a) | $-1,009 | $-967 | $-1,026 | $-1,024 | $-1,670 |